Literature DB >> 6697069

Hypoglycaemia due to azapropazone-tolbutamide interaction.

D G Waller, D Waller.   

Abstract

We report a case of hypoglycaemia due to a 'first-dose' interaction between azapropazone and tolbutamide. The mechanism was probably by displacement of tolbutamide from protein binding sites, and it is recommended that azapropazone should be avoided in patients receiving tolbutamide.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6697069     DOI： 10.1093/rheumatology/23.1.24

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN： 0263-7103


  3 in total

Review 1.  The problems and pitfalls of NSAID therapy in the elderly (Part II).

Authors:  A G Johnson; R O Day
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

Review 2.  Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance.

Authors:  A G Johnson; P Seideman; R O Day
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

Review 3.  Pharmacotherapy of type 2 diabetes mellitus: an update on drug-drug interactions.

Authors:  Muhammad Amin; Naeti Suksomboon
Journal:  Drug Saf       Date:  2014-11       Impact factor: 5.606
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.